Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Summary

This study will compare GSK Biologicals' DTPa/Hib vaccine to separately administered DTPa and Hib vaccines in Chinese infants 3, 4 \& 5 months of age, in terms of safety and immunogenicity.

Timeline

Start

2007-01-03

Primary completion

2007-06-01

Completion

2007-06-25

Publications

• Background Li YP, Zhang SM, Ye Q. [Safety and immunogenicity of the diphtheria, tetanus, accellular pertussis plus hemophilus influenza type b combined vaccine (DTaP-Hib) to Chinese infants]. Zhongguo Yi Miao He Mian Yi. 2010 Apr;16(2):97-104. Chinese.

Drugs

Indications